Aurinia Pharmaceuticals (AUPH) grants PSUs and stock options to CFO
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Hearne Michael S reported acquisition or exercise transactions in this Form 4 filing.
Aurinia Pharmaceuticals Inc. reported that Chief Financial Officer Michael S. Hearne received new equity compensation awards. He was granted 116,144 performance stock units, each representing a contingent right to receive one common share, and 70,230 employee stock options.
The PSUs vest in multiple tranches based on Aurinia’s share price performance and time-based conditions, while the options have a strike price of $15.28 per share and expire on May 18, 2036. These are compensation-related grants rather than open-market share purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Hearne Michael S
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) | 70,230 | $0.00 | -- |
| Grant/Award | Common Stock | 116,144 | $0.00 | -- |
Holdings After Transaction:
Employee Stock Option (right to buy) — 70,230 shares (Direct, null);
Common Stock — 116,144 shares (Direct, null)
Footnotes (1)
- Each performance stock unit ("PSU") represents a contingent right to receive one common share of the Issuer. 46,820 PSUs vest in four tranches upon the Issuer's common shares achieving four progressively higher target prices, with respective one year retention periods per tranche achievement. 69,324 PSUs vest in two tranches at the three and five year anniversary date of grant if the Issuer's common shares achieve target prices that represent significant increases from the share price on date of grant before the respective vesting date. 33% vest on the 1-year anniversary of the grant date, and the remaining 67% vest equally in monthly installments over the following 2 years.
Key Figures
Performance stock units granted: 116,144 units
Stock options granted: 70,230 options
Option exercise price: $15.28 per share
+3 more
6 metrics
Performance stock units granted
116,144 units
Granted to CFO Michael S. Hearne on May 18, 2026
Stock options granted
70,230 options
Employee stock options granted on May 18, 2026
Option exercise price
$15.28 per share
Strike price of employee stock options
Option expiration date
May 18, 2036
Expiration for granted employee stock options
Performance-based PSU tranche
46,820 PSUs
Vest in four tranches upon achieving target share prices
Time- and performance-based PSU tranche
69,324 PSUs
Vest in two tranches at 3 and 5 years if price targets met
Key Terms
performance stock unit ("PSU"), Employee Stock Option (right to buy), vest, target prices
4 terms
performance stock unit ("PSU") financial
"Each performance stock unit ("PSU") represents a contingent right to receive one common share"
Employee Stock Option (right to buy) financial
"Employee Stock Option (right to buy) with an exercise price of 15.2800"
vest financial
"46,820 PSUs vest in four tranches upon the Issuer's common shares achieving four progressively higher target prices"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
target prices financial
"PSUs vest when the Issuer's common shares achieve target prices that represent significant increases"
FAQ
What did Aurinia Pharmaceuticals (AUPH) CFO Michael Hearne report on this Form 4?
The Form 4 reports that CFO Michael S. Hearne received equity compensation awards: 116,144 performance stock units and 70,230 employee stock options. These awards are grants from Aurinia Pharmaceuticals, not open-market share purchases or sales by the executive.
How many performance stock units were granted to the Aurinia (AUPH) CFO?
Michael Hearne was granted 116,144 performance stock units. Each PSU represents a contingent right to receive one Aurinia common share, subject to various vesting conditions tied to share price targets and time-based requirements over several years.
What stock options did the Aurinia (AUPH) CFO receive in this filing?
He received 70,230 employee stock options with an exercise price of $15.28 per share. These options are exercisable into Aurinia common stock and have an expiration date of May 18, 2036, providing long-term equity-based compensation potential.
How do the Aurinia (AUPH) CFO’s performance stock units vest?
46,820 PSUs vest in four tranches when Aurinia’s common shares reach progressively higher target prices, each with a one-year retention period. The remaining 69,324 PSUs vest in two tranches at three and five years if ambitious share price targets are achieved before those dates.
What is the vesting schedule for the Aurinia (AUPH) CFO’s stock options?
For the granted stock options, 33% vest on the one-year anniversary of the grant date. The remaining 67% then vest in equal monthly installments over the following two years, creating a three-year total vesting period tied to continued service.